NIH Common Fund Data Ecosystem: LINCS (CFDE-LINCS) FAIR Rubric
A rubric for evaluating the FAIRness of LINCS Resource
Tags: nihcommonfund
URL(s):
View AssociationsRubric Assessments (33)
| Assessment | Metrics | Date | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Target | Project | Contact information is provided for the creator(s) of the dataset. | Globally unique identifier | Machine-readable metadata | Standardized metadata | Resource identifier in metadata | Open, Free, Standardized Access protocol | Digital resource license | Metadata license | The institution that created this dataset is available | A biological assay is present and resolvable in CFDE-specified ontology (OBI) | A relevant anatomical part is present and resolvable in the UBERON Ontology | A relevant disease is present and resolvable in the MONDO Ontology | A relevant file type is present and resolvable in the EDAM Ontology | A relevant taxonomy is present and resolvable in the NCBITaxon Ontology | A relevant cell line is present and resolvable in the Cellosaurus Ontology | A landing page exists and is accessible | Relevant Drug or Small Molecule terms are resolvable in PubChem | Relevant Gene IDs are resolvable as NCBI Entrez Genes | ||
| L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (December 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS chemical perturbagen signatures | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | maybe (0.48) | yes (1.00) | yes (0.88) | nobut (0.25) | Jun 23, 2021 | |||
| Transcriptomics dataset (August 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| PeptideModifiedSequence_A375_f53da3_NoNAs_n288x5203 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| Perturbational proteomic and transcriptional profiles of drug perturbations from Broad Institute LINCS Proteomic Characterization Center for Signaling and Epigenetics and Broad Institute LINCS Center for Transcriptomics | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | Jun 23, 2021 | |||||
| Transcriptomics dataset (June 2015) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS consensus gene (CGS) knockdown signatures | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | maybe (0.48) | yes (1.00) | maybe (0.52) | Jun 23, 2021 | ||||
| Broad Institute L1000 Connectivity Map and RNAseq gene expression profiles on tissue samples from the GTEx project | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS L1000 Chemical Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (0.99) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.47) | yes (1.00) | Jun 23, 2021 | |||||
| iPSC (Exp 1) - ALS, SMA and Control (unaffected) subject-derived iPSC lines - RNA-seq | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS L1000 shRNA Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.49) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS L1000 CRISPR Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.50) | yes (1.00) | Jun 23, 2021 | |||||
| L1000 Dataset -small molecule perturbagens- LINCS Phase 1 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | Jun 23, 2021 | |||||
| VMSiteFlankCentric_A375_f53da3_NoNAs_n288x4433 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS gene overexpression signatures | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | maybe (0.50) | yes (1.00) | maybe (0.52) | Jun 23, 2021 | ||||
| GCP aggregated data - Chemical perturbations | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS targeted proteomics signatures | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.39) | yes (1.00) | yes (0.83) | nobut (0.25) | Jun 23, 2021 | |||
| LINCS L1000 Antibody Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.50) | yes (1.00) | Jun 23, 2021 | |||||
| Transcriptomics dataset (March 2016) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | maybe (0.50) | Jun 23, 2021 | ||||
| LINCS L1000 siRNA Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.50) | yes (1.00) | Jun 23, 2021 | |||||
| iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - RNA-seq | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| EDS-1014 | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | no (0.00) | no (0.00) | no (0.00) | nobut (0.25) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | no (0.00) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS L1000 Ligand Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.50) | yes (1.00) | Jun 23, 2021 | |||||
| P100 aggregated data - Chemical perturbations | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | no (0.00) | yes (1.00) | yesbut (0.75) | no (0.00) | yes (1.00) | nobut (0.25) | nobut (0.25) | nobut (0.25) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | Jun 23, 2021 | |||||
| LINCS L1000 Overexpression Perturbations (2021) | LINCS: Assessment of NIH Common Fund Resources with C2M2 |
|
no (0.00) | yes (1.00) | yes (1.00) | yesbut (0.75) | no (0.00) | no (0.00) | nobut (0.25) | yes (1.00) | nobut (0.25) | nobut (0.25) | yes (1.00) | maybe (0.49) | yes (1.00) | Jun 23, 2021 | |||||
